MEREO BIOPHARMA GROUP PLC Reclassification Adjustments On Exchange Differences On Translation Net Of Tax
MEREO BIOPHARMA GROUP PLC (MREO) reported Reclassification Adjustments On Exchange Differences On Translation Net Of Tax of -GBP 1.49 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-07.
Discontinued › Notes
ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax · last filed 2023-09-07
| Period end | Reclassification Adjustments On Exchange Differences On Translation Net Of Tax 6 month | Reclassification Adjustments On Exchange Differences On Translation Net Of Tax 12 month |
|---|---|---|
| 2023-06-30 | -1.49M GBP 6-K · filed 2023-09-07 | |
| 2022-12-31 | 1.83M GBP 20-F · filed 2023-03-28 | |
| 2022-06-30 | 1.77M GBP 6-K · filed 2023-09-07 | |
| 2021-12-31 | 191.00K GBP 20-F · filed 2023-03-28 | |
| 2021-06-30 | 26.00K GBP 6-K · filed 2022-11-02 | |
| 2020-12-31 | -349.00K GBP 20-F · filed 2023-03-28 | |
| 2020-06-30 | -1.32M GBP 6-K · filed 2021-11-02 | |
| 2019-12-31 | 499.00K GBP 20-F · filed 2022-03-31 | |
| 2019-06-30 | -711.00K GBP 6-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |